Western blotting revealed that phospho mTOR (pmTOR) and pS6K were expressed in the control group; high mTOR expression in human clinical triple-negative breast cancer was reproduced in our in vivo xenograft model. The gene discussed is MTOR; the disease is triple-negative breast carcinoma.